Celesio AG buy Putcall
Summary
This prediction ended on 10.02.11 with a price of €18.56. With a performance of 1.39%, the BUY prediction by Putcall for Celesio AG closed with a slight gain. Putcall has 50% into this predictionCelesio is a listed healthcare company that provides wholesale, delivery, and retail distribution services for pharmaceutical and healthcare products in Europe. The company operates through its three segments: Prescription Retail, Pharmacy Wholesale, and Consumer Solutions, and its services cater to individual customers, hospitals, and healthcare professionals. Celesio also offers digital healthcare solutions and operates pharmacies across Europe. As of July 2021, Celesio's stock is trading at approximately €25 per share on the Frankfurt Stock Exchange.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Celesio AG | - | - | - | - |
iShares Core DAX® | 3.054% | -1.396% | 15.789% | 12.675% |
iShares Nasdaq 100 | 4.389% | -5.391% | 29.906% | 39.325% |
iShares Nikkei 225® | 5.386% | -3.105% | 16.065% | 8.150% |
iShares S&P 500 | 2.955% | -3.011% | 25.903% | 37.650% |
Comments by Putcall for this prediction
In the thread Celesio AG diskutieren
Kauf
Ebenfalls Potenzial hat laut dem Profi Celesio. "Der große internationale Pharmahändler und -dienstleister macht pro Jahr deutlich über 20 Milliarden Euro Umsatz", sagt Kühn. Positiv bei Celesio sei die rasante Durchdringung der BRIC-Wachstumsmärkte, vor allem Brasiliens. "Um Celesio ranken sich immer wieder Übernahmegerüchte", so der Stratege weiter. "Zuletzt wurde dem US-Großhändler McKesson Interesse nachgesagt. Mein Kursziel heißt 25 Euro."